Allogeneic HSCT with reduced intensity conditioning regimens in high risk patients with myelofibrosis

被引：0
|
作者：
Rondelli, D
Barosi, G
Bacigalupo, A
Prchal, JT
Popat, U
Alessandrino, EP
Spivak, JL
Hoffman, R
Fruchtman, S
机构：
[1] Univ Illinois, Chicago, IL 60680 USA
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
[3] Osped San Martino Genova, Genoa, Italy
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Johns Hopkins Univ, Baltimore, MD 21218 USA
[6] Mt Sinai Sch Med, New York, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2003.12.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Allogeneic HSCT for adult lymphoma patients.: A retrospective study of myeloablative compared to reduced-intensity conditioning
    Hägglund, H
    Remberger, M
    Ljungman, P
    Aschan, J
    Löfgren, C
    Ringden, O
    Kimby, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S254 - S254
  • [32] More frequently employed conditioning regimens in allo-HSCT: conventional or reduced intensity but myeloablative
    Rodriguez, M.
    Barragan, L.
    Lizardi, A.
    Ferreiro, J.
    Alkorta, A.
    Artola, T.
    Perez, E.
    Caminos, N.
    Sirvent, M.
    Araiz, M.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S332 - S332
  • [33] Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
    Gagelmann, N.
    Badbaran, A.
    Ditschkowski, M.
    Bogdanov, R.
    Panagiota, V
    Thol, F.
    Robin, M.
    Heuser, M.
    Beelen, D.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 58 - 59
  • [34] Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning
    Lee, CK
    Badros, A
    Barlogie, B
    Morris, C
    Zangari, M
    Fassas, A
    van Rhee, F
    Cottler-Fox, M
    Jacobson, J
    Thertulien, R
    Muwalla, F
    Mazher, S
    Anaissie, E
    Tricot, G
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (01) : 73 - 80
  • [35] Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies
    Haskologlu, Sule
    Bal, Sevgi Kostel
    Islamoglu, Candan
    Altun, Demet
    Kendirli, Tanil
    Dogu, Esin Figen
    Ikinciogullari, Aydan
    PEDIATRIC TRANSPLANTATION, 2018, 22 (07)
  • [36] A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis
    George, B.
    Kerridge, I.
    Gottlieb, D.
    Huang, G.
    Hertzberg, M.
    Svennilson, J.
    Bradstock, K.
    BONE MARROW TRANSPLANTATION, 2008, 42 (08) : 567 - 568
  • [37] A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis
    B George
    I Kerridge
    D Gottlieb
    G Huang
    M Hertzberg
    J Svennilson
    K Bradstock
    Bone Marrow Transplantation, 2008, 42 : 567 - 568
  • [38] Reduced-Intensity Conditioning Regimens for Allogeneic Transplantation in Children with Acute Lymphoblastic Leukemia
    Verneris, Michael R.
    Eapen, Mary
    Duerst, Reggie
    Carpenter, Paul A.
    Burke, Michael J.
    Afanasyev, B. V.
    Cowan, Morton J.
    He, Wensheng
    Krance, Robert
    Li, Chi-Kong
    Tan, Poh-Lin
    Wagner, John E.
    Davies, Stella M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1237 - 1244
  • [39] Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.
    Khera, Nandita
    Storer, Amy Emmert Barry
    Sandmaier, Brenda M.
    Alyea, Edwin
    Lee, Stephanie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Comparison of two reduced intensity allogeneic peripheral blood stem transplant conditioning regimens
    Raflores, MB
    Rossetti, JM
    Shadduck, RK
    Lister, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 38 - 38
12345